As the prevalence of Age-Related Macular Degeneration (AMD) continues to grow, so does the need for early detection of conversion from Dry AMD to Wet AMD. The Reichert Foresee PHP® Preferential Hyperacuity Perimeter is the only FDA cleared method for monitoring the conversion of Intermediate AMD (Dry) to Choroidal Neovascularization (Wet AMD). Based on the phenomenon of hyperacuity (Vernier), the Foresee PHP is a non-invasive, quick, and easy-to-use perimeter that can detect early Wet AMD before symptoms become noticeable to patients, enabling clinicians to refer for treatment when it is most effective.